
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
Ned Milenkovich discusses how health care professionals benefit by the regulations within USP800.
Ned Milenkovich discusses how health care professionals benefit by the regulations contained within USP800.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Subscribe





